Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence

Some 30–50% of the global population and almost 20% of the European population actually suffer from chronic pain, which presents a tremendous burden to society when this pain turns into a disability and hospitalization. Palmitoylethanolamide (PEA) has been demonstrated to improve pain in preclinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Scuteri, Damiana, Guida, Francesca, Boccella, Serena, Palazzo, Enza, Maione, Sabatino, Rodríguez-Landa, Juan Francisco, Martínez-Mota, Lucia, Tonin, Paolo, Bagetta, Giacinto, Corasaniti, Maria Tiziana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414729/
https://www.ncbi.nlm.nih.gov/pubmed/36015298
http://dx.doi.org/10.3390/pharmaceutics14081672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414729/
https://www.ncbi.nlm.nih.gov/pubmed/36015298
http://dx.doi.org/10.3390/pharmaceutics14081672

Ejemplares similares